Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study
Titel:
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study
Auteur:
Frumovitz, Michael Chisholm, Gary B. Jhingran, Anuja Ramalingam, Preetha Flores-Legarreta, Alejandra Bhosale, Priya Gonzales, Naomi R. Hillman, R. Tyler Salvo, Gloria